U.S. Markets close in 3 hrs 9 mins
  • S&P 500

    4,527.54
    -49.56 (-1.08%)
     
  • Dow 30

    34,523.71
    -116.08 (-0.34%)
     
  • Nasdaq

    15,037.62
    -343.70 (-2.23%)
     
  • Russell 2000

    2,161.16
    -45.17 (-2.05%)
     
  • Crude Oil

    67.08
    +0.58 (+0.87%)
     
  • Gold

    1,781.00
    +18.30 (+1.04%)
     
  • Silver

    22.13
    -0.15 (-0.67%)
     
  • EUR/USD

    1.1312
    +0.0006 (+0.0566%)
     
  • 10-Yr Bond

    1.3800
    -0.0680 (-4.70%)
     
  • Vix

    30.89
    +2.94 (+10.52%)
     
  • GBP/USD

    1.3239
    -0.0063 (-0.4740%)
     
  • USD/JPY

    112.8300
    -0.3790 (-0.3348%)
     
  • BTC-USD

    55,028.30
    -1,592.01 (-2.81%)
     
  • CMC Crypto 200

    1,397.60
    -44.16 (-3.06%)
     
  • FTSE 100

    7,122.32
    -6.89 (-0.10%)
     
  • Nikkei 225

    28,029.57
    +276.20 (+1.00%)
     

New Strong Sell Stocks for July 20th

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:

Aeva Technologies, Inc. AEVA is building the next-generation of sensing and perception for autonomous vehicles and beyond. The Zacks Consensus Estimate for its current year earnings has been revised 2.8% downward over the last 30 days.

Baidu, Inc. BIDU provides internet search services. The Zacks Consensus Estimate for its current year earnings has been revised 4.2% downward over the last 30 days.

CymaBay Therapeutics, Inc. CBAY is a biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 0.9% downward over the last 30 days.

Dicerna Pharmaceuticals, Inc. DRNA is focused on the discovery and development of innovative treatments for rare inherited diseases involving the liver and for cancers. The Zacks Consensus Estimate for its current year earnings has been revised 5.7% downward over the last 30 days.

Ferrari N.V. RACE is engaged in designing, manufacturing and selling sports cars. The Zacks Consensus Estimate for its current year earnings has been revised 4.3% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Baidu, Inc. (BIDU) : Free Stock Analysis Report
 
Dicerna Pharmaceuticals, Inc. (DRNA) : Free Stock Analysis Report
 
Ferrari N.V. (RACE) : Free Stock Analysis Report
 
CymaBay Therapeutics Inc. (CBAY) : Free Stock Analysis Report
 
Aeva Technologies, Inc. (AEVA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research